Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

"It is estimated that by 2030, 30 million GLP-1 [receptor agonist] prescriptions will have been dispensed in the U.S. Despite the rarity of NAION, the large number of users of these drugs can ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

GLP-1s may suppress the centers in the brain responsible for cravings—the same mechanism that could contribute to weight ... but rather a sort of side benefit of GLP-1 agonists. The researcher likened ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

A new study reports that GLP-1 medications may provide benefits ... showing that we indeed have GLP-1 receptors in our brain. These are likely mechanisms by which GLP-1 may impact neuropsychiatric ...